December 20, 2016 / 3:40 PM / 8 months ago

BRIEF-Pharmstandard to terminate public status, apply for delisting from Moscow Exchange

Dec 20 (Reuters) - Pharmstandard :

* Says board decides to terminate public status of the company and apply for delisting from Moscow Exchange

* The final decision will be made by the extraordinary general meeting of shareholders on Jan. 30, 2017

* Earlier Pharmstandard said Augment Investment Limited acquired 100 pct stake in the company as a result of buy-out offer

* London Stock Exchange has delisted Pharmstandard's global depositary receipts (GDRs) as of Nov. 29 Source text - bit.ly/2hn3s5u

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below